Europe is facing a new health concern as mpox makes a comeback, raising fears across the continent.
However, European health officials have reassured the public that there’s no need to hit the panic button just yet—border controls and mass vaccinations are not on the table.
A cautious approach to mpox
After meeting with experts from the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA), the European Health Security Committee concluded that the risk of mpox spreading widely across Europe remains low.
While the virus has caused over 500 deaths in the Democratic Republic of Congo, and while there is a case reported in Sweden, officials are choosing caution over alarm.
A European Commission spokesperson noted that, even though the World Health Organization (WHO) has declared mpox a global health emergency, Europe should not treat it as a public health emergency in Europe right now.
“The HSC members agreed on the importance of a closely coordinated approach and the need to continue monitoring the situation very closely,” the spokesperson explained.
(Image courtesy of NIAID via Wikimedia Commons)
No need for mass vaccination
With concerns growing, some European countries are ramping up their health monitoring and public awareness efforts.
However, the decision not to roll out a mass vaccination program across the European Union (EU) is based on the fact that mpox does not seem to be spreading easily in Europe.
Currently, only specific high-risk groups are being advised to get vaccinated, and there is no plan to extend this to the general population.
This approach fits with what the WHO has been saying—that mpox is not “the next COVID.”
While this new strain of the virus, called ‘clade I,’ is more serious, it is not as contagious as COVID-19. Furthermore, authorities are better equipped to manage its spread.
The EU’s focus remains on preparedness and awareness rather than widespread vaccination.
(Image courtesy of Surprising_SnapShots via Pixabay)
No restrictions for now
For travelers and migrants, the decision not to impose border controls means things will carry on as usual when entering Europe.
However, just because there are no new restrictions does not mean officials are not paying attention.
Countries like Spain are teaming up with airports and airlines to make sure travelers have the information they need about mpox and how to stay safe.
This cautious approach goes hand in hand with the upcoming launch of the European Travel Information and Authorization System (ETIAS), which aims to improve travel security without imposing unnecessary barriers.
The ETIAS, designed to pre-screen travelers from visa-exempt countries, will likely play a role in monitoring potential health risks, including mpox, without disrupting the freedom of movement within the Schengen Area.
Free movement in the EU
The EU’s decision not to enforce border controls or mass vaccinations also reflects a broader approach to immigration.
By avoiding drastic measures, the EU is signaling that it is committed to keeping borders open and supporting free movement, even in the face of health concerns.
This approach aligns with the EU’s overall philosophy on migration, which focuses more on integration and protecting human rights than on restrictions.
As the situation develops, any changes in immigration policy will likely be more about targeted actions rather than sweeping changes, ensuring that Europe remains welcoming while still prioritizing public health.
A balanced response
Europe’s response to the mpox outbreak shows a careful balance between caution and maintaining normalcy.
By not rushing into border controls or mass vaccinations, the EU is showing confidence in its ability to handle the virus while making sure people’s rights and freedoms aren’t unnecessarily affected.
It is a reminder that staying informed and working together is the best way to handle new health challenges.